Holdings (as at 2026-01-21)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Organon & Co. 2.89%
Molina Healthcare, Inc. 2.42%
Medpace Holdings, Inc. 2.38%
Incyte Corporation 2.29%
Natera, Inc. 2.29%
Pfizer Inc. 2.24%
Cardinal Health, Inc. 2.19%
Solventum Corporation 2.19%
Acadia Healthcare Company, Inc. 2.18%
Eli Lilly and Company 2.17%
Ionis Pharmaceuticals, Inc. 2.17%
HCA Healthcare, Inc. 2.15%
Biogen Inc. 2.12%
Universal Health Services, Inc. (Class B) 2.02%
Penumbra, Inc. 1.99%
Insmed Incorporated 1.94%
Sotera Health Company 1.86%
Perrigo Company Plc 1.85%
Merck & Co., Inc. 1.82%
Elevance Health Inc. 1.82%
Amgen Inc. 1.81%
Repligen Corporation 1.79%
IDEXX Laboratories, Inc. 1.78%
The Cigna Group 1.72%
Sarepta Therapeutics, Inc. 1.71%
Regeneron Pharmaceuticals, Inc. 1.68%
Abbott Laboratories 1.66%
Zimmer Biomet Holdings, Inc. 1.66%
United Therapeutics Corporation 1.66%
QIAGEN N.V. 1.60%
Apellis Pharmaceuticals, Inc. 1.44%
Globus Medical, Inc. (Class A) 1.40%
Labcorp Holdings Inc. 1.39%
Quest Diagnostics Incorporated 1.38%
Halozyme Therapeutics, Inc. 1.38%
Chemed Corporation 1.37%
Gilead Sciences, Inc. 1.36%
Exelixis, Inc. 1.32%
Bristol-Myers Squibb Company 1.31%
Neurocrine Biosciences, Inc. 1.24%
Tenet Healthcare Corporation 1.24%
BioMarin Pharmaceutical Inc. 1.24%
Encompass Health Corporation 1.21%
Intuitive Surgical, Inc. 1.20%
Alnylam Pharmaceuticals, Inc. 1.19%
Revvity, Inc. 1.04%
Certara, Inc. 0.95%
Align Technology, Inc. 0.94%
ResMed Inc. 0.93%
Becton, Dickinson and Company 0.92%
Johnson & Johnson 0.91%
UnitedHealth Group Incorporated 0.91%
Humana Inc. 0.91%
Medtronic Plc 0.90%
Waters Corporation 0.90%
Henry Schein, Inc. 0.90%
Vertex Pharmaceuticals Incorporated 0.88%
Zoetis Inc. 0.86%
GE HealthCare Technologies Inc. 0.85%
AbbVie Inc. 0.82%
Illumina, Inc. 0.47%
Thermo Fisher Scientific Inc. 0.45%
Tempus AI, Inc. (Class A) 0.45%
Elanco Animal Health Incorporated 0.43%
Baxter International Inc. 0.42%
Agilent Technologies, Inc. 0.42%
Inspire Medical Systems, Inc. 0.42%
Steris Plc 0.42%
Royalty Pharma Plc (Class A) 0.42%
The Cooper Companies, Inc. 0.41%
Insulet Corporation 0.41%
Edwards Lifesciences Corporation 0.40%
Veeva Systems Inc. (Class A) 0.40%
Boston Scientific Corporation 0.39%
West Pharmaceutical Services, Inc. 0.38%
Viking Therapeutics, Inc. 0.38%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.